Assenagon Asset Management S.A. raised its stake in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 39.5% in the second quarter, Holdings Channel reports. The institutional investor owned 2,455,402 shares of the semiconductor company’s stock after buying an additional 695,146 shares during the quarter. Synopsys comprises about 1.4% of Assenagon Asset Management S.A.’s portfolio, making the stock its 12th biggest position. Assenagon Asset Management S.A.’s holdings in Synopsys were worth $1,095,281,000 as of its most recent filing with the Securities & Exchange Commission.
Several other hedge funds and other institutional investors have also recently modified their holdings of the stock. Mechanics Bank Trust Department purchased a new stake in shares of Synopsys in the second quarter worth about $219,000. Trust Asset Management LLC lifted its stake in Synopsys by 2.1% in the 2nd quarter. Trust Asset Management LLC now owns 2,076 shares of the semiconductor company’s stock worth $926,000 after purchasing an additional 43 shares in the last quarter. Dynamic Advisor Solutions LLC boosted its holdings in Synopsys by 15.4% in the 2nd quarter. Dynamic Advisor Solutions LLC now owns 1,237 shares of the semiconductor company’s stock valued at $552,000 after purchasing an additional 165 shares during the period. GAMMA Investing LLC grew its position in shares of Synopsys by 14.2% during the 2nd quarter. GAMMA Investing LLC now owns 4,850 shares of the semiconductor company’s stock valued at $2,163,000 after purchasing an additional 603 shares in the last quarter. Finally, CoreCap Advisors LLC increased its holdings in shares of Synopsys by 333.3% in the second quarter. CoreCap Advisors LLC now owns 234 shares of the semiconductor company’s stock worth $104,000 after purchasing an additional 180 shares during the period. 85.47% of the stock is currently owned by institutional investors.
Synopsys Stock Performance
Shares of NASDAQ SNPS opened at $405.98 on Friday. The stock’s 50-day moving average is $434.62 and its 200 day moving average is $447.00. The stock has a market cap of $77.74 billion, a price-to-earnings ratio of 93.98, a P/E/G ratio of 2.35 and a beta of 1.23. Synopsys, Inc. has a 1-year low of $366.00 and a 1-year high of $632.99. The company has a current ratio of 1.43, a quick ratio of 1.32 and a debt-to-equity ratio of 0.33.
Insider Transactions at Synopsys
In other news, CEO Sassine Ghazi sold 14,603 shares of the business’s stock in a transaction dated Monday, June 15th. The stock was sold at an average price of $458.96, for a total value of $6,702,192.88. Following the completion of the sale, the chief executive officer owned 75,020 shares of the company’s stock, valued at approximately $34,431,179.20. The trade was a 16.29% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Shelagh Glaser sold 3,394 shares of the stock in a transaction dated Friday, June 12th. The shares were sold at an average price of $450.02, for a total value of $1,527,367.88. Following the sale, the chief financial officer owned 14,358 shares of the company’s stock, valued at $6,461,387.16. This represents a 19.12% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 0.56% of the company’s stock.
Wall Street Analyst Weigh In
Several equities research analysts recently issued reports on SNPS shares. Piper Sandler raised Synopsys from a “neutral” rating to an “overweight” rating and lifted their price objective for the company from $450.00 to $550.00 in a research note on Tuesday, June 23rd. Zacks Research raised Synopsys from a “hold” rating to a “strong-buy” rating in a report on Tuesday, June 30th. Stifel Nicolaus lifted their price target on Synopsys from $550.00 to $600.00 and gave the company a “buy” rating in a research report on Thursday, May 28th. Needham & Company LLC restated a “buy” rating and issued a $580.00 price objective on shares of Synopsys in a research report on Thursday, May 28th. Finally, Berenberg Bank set a $633.00 target price on shares of Synopsys in a research note on Wednesday, May 27th. Two research analysts have rated the stock with a Strong Buy rating, ten have issued a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $570.06.
Check Out Our Latest Analysis on SNPS
About Synopsys
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front?end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape?out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Featured Stories
- Five stocks we like better than Synopsys
- Sandisk Just Delivered a Blowout Quarter—Here’s Why the Stock Is Falling
- 4 Oil and Gas ETF Plays as Prices Stay Sky-High
- What Tesla Stands to Lose If It Walks Away From China
- Disney Sets Up for a Magical Year in 2027
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
